Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung

Oncology Reports

Volumn 9, Issue 4, 2002, Pages 835-838

  Ikehara, Mizuki ^a   Oshita, Fumihiro ^a   Kameda, Yoichi ^a   Ito, Hiroyuki ^a   Ohgane, Naoki ^a   Suzuki, Rie ^a   Saito, Haruhiro ^a   Yamada, Kouzo ^a   Noda, Kazumasa ^a   Mitsuda, Aki ^a  

^a KANAGAWA CANCER CENTER   (Japan)

Author keywords

Non small cell lung cancer; Survivin; Vessel invasion

Indexed keywords

BIRC5 PROTEIN, HUMAN; CYSTEINE PROTEINASE INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CYSTEINE PROTEINASE INHIBITORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 17144460538     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.4.835     Document Type: Article

References (13)

1. Fukuse T, Hirata T, Naiki H, et al: Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer. Cancer Res 60: 242-244, 2000. (Pubitemid 30070742)
2. Tomizawa Y, Nakajima T, Kohno T, et al: Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma. Cancer Res 58: 5478-5483, 1998. (Pubitemid 28551133)
3. Ohta Y, Tomita Y, Oda M, et al: Tumor angiogenesis and recurrence in stage I non-small cell lung cancer. Ann Thorac Surg 68: 1034-1038, 1999. (Pubitemid 29526880)
4. Herbst RS, Yano S, Kuniyasu H, et al: Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin Cancer Res 6: 790-797, 2000. (Pubitemid 30159331)
5. Khuri FR, Lotan R, Kemp BL, et al: Retinoic acid receptor-β as a prognostic indicator in stage I non-small cell lung cancer. J Clin Oncol 18: 2798-2804, 2000. (Pubitemid 30623478)
6. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921, 1997. (Pubitemid 27353455)
7. Monzo M, Rosell R, Felip E, et al: A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small cell lung cancers. J Clin Oncol 17: 2100-2104, 1999. (Pubitemid 29318841)
8. Noguchi M, Morikawa A, Kawasaki M, et al: Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 15: 2844-2852, 1995.
9. Yokose T, Suzuki K, Nagai K, et al: Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Lung Cancer 29: 179-188, 2000.
10. Tang X, Khuri FR, Lee J J, et al: Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small cell lung cancer. J Natl Cancer Inst 92: 1511-1516, 2000.
11. Cohen O, Inbal B, Kissil IL, et al: DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain. I Cell Biol 146: 141-148, 1999. (Pubitemid 29349970)
12. Oshita F, Nomura I, Yamada K, et al: Detection of K-ras mutation of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesions. Clin Cancer Res 5: 617-620, 1999. (Pubitemid 29131972)
13. Van Zandwijk N, Smit EF, Kramer GWP, et al: Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol 18: 2658-2664, 2000. (Pubitemid 30463547)